InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,384.97
(
0.76%
)
US TECH 100
18,302.00
(
1.37%
)
Dow Jones
39,442.99
(
0.22%
)
Brent Oil
80.82
(
-0.96%
)
Bitcoin
59,580.91
(
0.38%
)
Post# of 252865
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

xray72

Send PM Follow Ignore
Followers 0
Posts 7
Boards Moderated 0
Alias Born 11/22/2010

xray72

Re: None

Wednesday, 01/26/2011 4:50:28 AM

Wednesday, January 26, 2011 4:50:28 AM

Post# of 252865
Could it be that the aim behind Tevas most recent PR maneuver is not just to make MNTA and TEVA shareholders believe that approval of t-lovenox is imminent but is also aiming at Sanofi for the ultimate blow to MNTA.
Just speculating but if Sanofi is taking Tevas comments at face value, couldn't Sanofi be tempted to prepare to launch an A-G (shortly) before another competitor (t-lov) is coming to the market?
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up